HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

‘Ant-type Insects’ And Expired Ingredients: FDA Warns Bioque Following Inspection

This article was originally published in The Rose Sheet

Executive Summary

Agency inspectors observed a range of insanitary conditions and practices at the Blacksburg, Virginia-based manufacturing site that turns out Bioque and Vouray skin-care products, causing the products to be adulterated, according to an FDA warning letter.

You may also be interested in...



Think FDA Inspections Are Painful Now? These Could Be The Good Old Days

ICMAD's recent regulatory workshop offered perspective from FDA's Linda Katz and industry experts on the inspection process for cosmetics facilities under current law. It's clear that FDA inspections can be an ordeal, but that would pale in comparison to challenges that could arise under the proposed Personal Care Products Safety Act.

FDA Warns PhytoCeuticals For Adulterated Cosmetics, Cancer Claims

Agency’s most recently posted warning letters to skin-care marketers include one to PhytoCeuticals for adulterated cosmetics, following an inspection of the company’s manufacturing facility. Osea Internacional and Face Naturals also draw warnings for claims that identify their products as unapproved drugs.

FDA Warns Enessa For Claims Violations, Diminish-Rosacea Treatment

Natural brand Enessa may have to discontinue or relabel its Diminish-Rosacea Treatment, as the name constitutes an unapproved drug claim, FDA suggests in a warning letter. Other claims cited by the agency pertain to cellular repair, collagen synthesis, anti-inflammatory benefits and improved micro-circulation.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

RS108636

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel